Last reviewed · How we verify
NCT04374747
Fruit and Vegetable Intervention in Lactating Women to Reduce Breast Cancer Risk
NA trial testing Dietary Counseling in Breast Cancer Female in 400 participants. Status unknown.
1 April 2024
Quick facts
| Lead sponsor | University of Massachusetts, Amherst |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 400 |
| Start date | 24 October 2019 |
| Primary completion | 1 April 2024 |
| Estimated completion | 1 April 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Dietary Counseling
Conditions studied
- Breast Cancer Female — all drugs for Breast Cancer Female →
- Inflammation — all drugs for Inflammation →
- Postpartum Weight Retention — all drugs for Postpartum Weight Retention →
- Diet, Healthy — all drugs for Diet, Healthy →
Sponsor
University of Massachusetts, Amherst
Who can join
18 and older, female only, with Breast Cancer Female or Inflammation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Mechanistic data show that compounds in fruits and vegetables have anti-inflammatory and anti-carcinogenic properties that can reduce breast cancer risk. However, observational and interventional studies have provided mixed results, and a recent report by the American Institute for Cancer Research (AICR) concludes that the data are insufficient but suggestive that non-starchy vegetables and foods containing carotenoids reduce risk. Measurement error, relatively low levels of carotenoid-rich fruit and vegetable intake in the study populations, emphasis on diet in later adulthood, and confounding factors likely contribute to the weak associations. Therefore, the investigators will conduct a randomized diet intervention trial in young women to assess the extent to which at least 8 to 10 daily servings of deeply pigmented and nutrient dense fruits and vegetables reduces biomarkers of breast cancer risk. The intervention is focused on breastfeeding women because: 1) pregnancy and lactation are normal early life course events; 2) the risk of pregnancy-associated breast cancer (PABC) is increased for up to 10 years postpartum; 3) a dietary intervention to reverse the detrimental molecular changes associated with puberty and pregnancy is more likely to be successful in younger than in older women;4) a diet rich in fruits and vegetables is hypothesized to reduce the inflammation during lactation/weaning and lower PABC risk; 5) postpartum lactating women may be a highly motivated population; and 6) breastmilk provides access to the breast microenvironment and breast epithelial cells to non-invasively assess the diet intervention directly in the breast. Four hundred nursing mothers will be randomly assigned to either the intervention arm, in which they are asked to increase fruit and vegetable intake to at least 8 to 10 daily servings for one year, or to a control condition in which participants receive a dietary guideline for breastfeeding mothers. Women in the intervention arm will receive counseling and boxes of fruits and vegetables for the first 20 weeks, after which they will continue to receive counseling. Changes in DNA methylation and cytokine profiles in breastmilk will be evaluated. Maternal weight and body fat distribution, and infant growth will be monitored. These results will greatly expand our knowledge of how diet alters molecular pathways in a specific organ, ultimately contributing to both breast cancer etiology and prevention.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Antioxidants for the Treatment of Breast Cancer: Are We There Yet?
Griñan-Lison C, Blaya-Cánovas JL, López-Tejada A, Ávalos-Moreno M, et al · · 2021 · cited 43× · PMID 33572626 · DOI 10.3390/antiox10020205 -
Halophilic Carotenoids and Breast Cancer: From Salt Marshes to Biomedicine.
Giani M, Montoyo-Pujol YG, Peiró G, Martínez-Espinosa RM. · · 2021 · cited 21× · PMID 34822465 · DOI 10.3390/md19110594 -
New Moms Wellness Study: the randomized controlled trial study protocol for an intervention study to increase fruit and vegetable intake and lower breast cancer risk through weekly counseling and supplemental fruit and vegetable box delivery in breastfeeding women.
Sturgeon SR, Sibeko L, Balasubramanian R, Arcaro KF. · · 2022 · cited 2× · PMID 36153518 · DOI 10.1186/s12905-022-01967-9 -
Subclinical mastitis during lactation: a modifiable risk factor for breast cancer?
Schneider SS, Pentecost BT, Banas AR, Dalier A, et al · · 2025 · PMID 41404433 · DOI 10.1016/j.mehy.2025.111810
Verify or expand the search:
- PubMed search for NCT04374747
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dietary Counseling
Trials testing the same drug.
- NCT07554417 — Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treat · Phase 4 · not yet recruiting
- NCT06574178 — Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Interventio · NA · recruiting
- NCT05682781 — Nutrition Intervention in Older Adults at Risk of Malnutrition · NA · completed
- NCT03815214 — Take Off Pounds After Stroke Trial (TOPS) · Phase 2 · completed
- NCT03872375 — Calorie Restriction and Brain Function in Mild Cognitive Impairment · NA · completed
Other recruiting trials for Breast Cancer Female
Currently open trials in the same condition.
- NCT07505797 — ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) · recruiting
- NCT07198724 — ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrin · Phase 1, PHASE2 · recruiting
- NCT07331506 — Validation of the Oncoliq Test for the Early Detection of Breast Cancer. · recruiting
- NCT07214883 — UCF MammoChat: Image Repository · recruiting
- NCT07120100 — Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Surviv · NA · recruiting
Other University of Massachusetts, Amherst trials
Trials by the same sponsor.
- NCT07211373 — Advancing Student Suicide Interventions With Scalable Technologies · NA · enrolling by invitation
- NCT06990997 — Effects of Aphasia Identification Cards on Service Workers' Comprehension of People With Aphasia · NA · recruiting
- NCT07016555 — Burning Mouth Syndrome: Symptoms and Management · EARLY_PHASE1 · recruiting
- NCT06412016 — Urban Gardening and Peer Nutritional Counseling for People With HIV and Food Insecurity · NA · active not recruiting
- NCT06399939 — The Function of Biphasic Sleep in Infants · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04374747 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Massachusetts, Amherst
- Last refreshed: 4 November 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04374747.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing